Prenatal screening for Down syndrome: The problem of recurrent false-positives

Prenatal Diagnosis

Volumn 24, Issue 5, 2004, Pages 389-392

  Wald, Nicholas J ^a   Huttly, Wayne J ^a   Rudnicka, Alicja R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Down syndrome screening; Quadruple test; Recurrent false positives

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A;

ARTICLE; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FETUS; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST;

DOWN SYNDROME; ENGLAND; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 2642513415     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.890     Document Type: Article

References (11)

1. Dar H, Merksamer R, Berdichevsky D, David M. 1996. Maternal serum marker levels in consecutive pregnancies: a possible genetic predisposition to abnormal levels. Am J Med Genet 61: 154-157.
2. Holding S, Cuckle H. 1994. Maternal serum screening for Down's syndrome taking account of the result in a previous pregnancy. Prenat Diagn 14: 321-324.
3. Larsen SO, Christiansen M, Norgaard-Pedersen B. 1998. Inclusion of serum marker measurements from a previous pregnancy improves Down syndrome screening performance. Prenat Diagn 18: 706-712.
4. Mooney RA, French CA, Saller DN, Peterson CJ, Arvan DA. 1995. Trends in maternal serum markers in successive pregnancies suggest additional maternal factors influence levels. Am J Med Genet 57(4): A285.
5. Rausch DN, Lambert-Messerlian GM, Canick JA. 2000. Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy. West J Med 173: 180-183.
6. Spencer K. 1997. Between pregnancy biological variability of maternal serum alpha fetoprotein and free beta hCG: implications for Down syndrome screening in subsequent pregnancies. Prenat Diagn 17: 39-45.
7. Spencer K. 2002. Between pregnancy biological variability of first trimester markers of Down syndrome and the implications for screening in subsequent pregnancies: an issue revisited. Prenat Diagn 22: 874-876.
8. Wald NJ, Cuckle HS. 1981. Raised maternal serum AFP levels in subsequent pregnancies. Lancet 1: 1103.
9. Wald NJ, Cuckle HS, Densem JW, et al. 1988. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297: 883-887.
10. Wald NJ, Densem JW, George L, et al. 1997. Inhibin-A in Down's syndrome pregnancies: revised estimate of standard deviation. Prenat Diagn 17: 285-290.
11. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. 1996. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 16: 143-153.